Vuori Kristiina MD
SEC CIK 1612627 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| INBX | Inhibrx Biosciences, Inc. | Dir | 20.4K | $300.0K | — | 3 | 2024-08-29 | 2024-10-03 |
Most active insiders at INBX, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Viking Global Opportunities Parent GP LLC | 10% | — | $11.29M |
| 2 | Lappe Mark | CEO, Dir | $2.65M | — |
| 3 | Kayyem Jon Faiz | Dir | $1.57M | — |
| 4 | FORSYTH DOUGLAS | Dir | $286.6K | — |
| 5 | MANHARD KIMBERLY | Dir | — | $279.0K |
Vuori Kristiina MD made no open-market trades at INBX in the last 12 months.
Transactions 3
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-10-07 | 2024-10-03 | INBX | Inhibrx Biosciences, Inc. | Vuori Kristiina MD | Dir | P - Purchase | $15.00 | +6,667 | 20.4K | +48% | +$100.0K | |
| M | 2024-09-12 | 2024-09-10+ | INBX | Inhibrx Biosciences, Inc. | Vuori Kristiina MD | Dir | P - Purchase | $15.07 | +6,636 | 13.8K | +93% | +$100.0K |
| 2024-09-03 | 2024-08-29 | INBX | Inhibrx Biosciences, Inc. | Vuori Kristiina MD | Dir | P - Purchase | $14.00 | +7,140 | 7,140 | New | +$100.0K |
Purchase Sale Sale after option exercise All abbreviations